Charles Gersbach and his colleagues are pursuing promising CRISPR technologies focused on controlling gene activity rather than permanently altering the genome.

The stem cell therapy market is witnessing strong growth driven by rising demand for regenerative medicine and advanced treatment options for chronic diseases such as cancer, diabetes, and ...

Mirai Bio, the innovation delivery partner for companies developing next generation nucleic acid medicines, today announced that it will present three abstracts at ASGCT 2026, including one oral ...

The CEO of the $1.5 billion neurotech startup, called Science Corporation, is preparing to implant its first biohybrid brain sensor in a human patient later this year.

McLaren Golf came to life thanks to a team of industry veterans who embraced building golf clubs worthy of the McLaren name.

Scientists have developed a breakthrough injectable biomaterial that travels through the bloodstream to repair damaged tissue ...

Robert Calderbank is Charles S. Sydnor Distinguished Professor of Computer Science and professor of mathematics at Trinity ...

Therapies like PRP and ACS have gained credibility when properly applied and studied, particularly in musculoskeletal conditions.

Students partnered with local newsrooms to solve real reporting problems and learned to start with the need, not the technology ...

No. 1 seed Duke edged No. 2 seed Virginia 74-70 in a thrilling ACC Tournament title game on Saturday night that could be enough to earn the Blue Devils the No. 1 overall seed in the 2026 NCAA ...

Editor's note: This story is part of a series about the Class of 2029 based on a survey conducted by The Chronicle in January and February 2026. You can read more about our methodology and limitations ...